Renaissance Technologies LLC Raises Holdings in Healthpeak Properties, Inc. $DOC

Renaissance Technologies LLC grew its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 45.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 813,568 shares of the real estate investment trust’s stock after acquiring an additional 255,730 shares during the quarter. Renaissance Technologies LLC’s holdings in Healthpeak Properties were worth $13,367,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of DOC. Norges Bank acquired a new stake in Healthpeak Properties in the 4th quarter worth approximately $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after purchasing an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after purchasing an additional 5,815,189 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in shares of Healthpeak Properties by 235.3% in the fourth quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock worth $56,477,000 after buying an additional 2,464,612 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

DOC has been the subject of several research reports. Citigroup lifted their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Mizuho upped their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, July 6th. Scotiabank raised their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 27th. JPMorgan Chase & Co. raised their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Finally, Royal Bank Of Canada lifted their price target on Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, May 14th. Four investment analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.62.

Healthpeak Properties Stock Performance

Shares of NYSE DOC opened at $21.83 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a 50 day simple moving average of $21.01 and a two-hundred day simple moving average of $18.65. The stock has a market cap of $15.05 billion, a price-to-earnings ratio of 68.21, a PEG ratio of 3.43 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.6%. Healthpeak Properties’s payout ratio is currently 381.25%.

Insider Buying and Selling

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.